Moleculin Biotech

MBRX • NASDAQ • Stock Fundamentals

Moleculin Biotech is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Walter V. Klemp, with a market cap of $13.1M.

Market Cap$13.1M

Employees18.0

CEOWalter V. Klemp

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026

Next EarningsAug 11, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Moleculin Biotech

Moleculin Biotech (MBRX) has a market capitalization of $13.1M and trades on NASDAQ.

Moleculin Biotech has approximately 18 employees.